-
Published02/06/2025
-
Today21/06/2025
-
Deadline30/06/2025
-
Opening of tenders30/06/2025
Utilities
- indicates text translated automatically in your browsing language
Supplies of medicines - Active substance rivaroxaban - ATC B01AF01 Text automatically translated in your browsing language Automatically translated
Note: Not all information for this procedure were successfully computed. Please consult linked documents for more details.
The subject of the public contract is the continuous supply of a medicinal product containing the active substance rivaroxaban from a specific manufacturer corresponding to the current prescription of doctors and intended for dispensing on prescription in the public part of the pharmacy. LP — XARELTO, pharmaceutical form 10MG TBL FLM 10, measuring unit 10X10MG, quantity 400 LP — XARELTO, pharmaceutical form 10MG TBL FLM 30, measuring unit 30X10MG, quantity 700 LP — XARELTO, pharmaceutical form 15MG TBL FLM 28, measuring unit 28X15MG, quantity 300 LP — XARELTO, pharmaceutical form 15MG TBL FLM 42, measuring unit 42X15MG, quantity 550 LP — XARELTO, pharmaceutical form 15MG TBL FLM 98, measuring unit 98X15MG, quantity 1 250 LP — XARELTO, pharmaceutical form 20MG TBL FLM 28, measuring unit 28X20MG, quantity 1 250 LP — XARELTO, pharmaceutical form 20MG TBL FLM 98, measuring unit 98X20MG, quantity 5 000 LP — XARELTO, pharmaceutical form 2,5MG TBL FLM 196, measuring unit 1X2.5, 150MG Text automatically translated in your browsing language Automatically translated
https://www.egordion.cz/nabidkaGORDION/profilTN
https://www.egordion.cz/nabidkaGORDION/profilTN
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.